Category: Artificial Intelligence

  • Honeywell Makes Strategic Investment in RapidSOS’s ER Data Platform

    What You Should Know: – Today, Honeywell announced it has made a strategic investment in RapidSOS, an NYC-based emergency response data platform, to further modernize and digitize the public safety communications process. – In addition to the strategic investment, Honeywell Connected Life Safety System (CLSS) will integrate with the RapidSOS emergency response data platform to provide faster, more accurate communications with 911 agencies. Terms of the investment were not […]

  • Infermedica raises a big round and demos new product

    Infermedica is a company that started by creating symptom checking and chatbot functionality in Poland back in 2012. It’s spread to delivering that patient-facing diagnosis functionality via API and now as preparation for a physician visit. Today they announce a $30m series B and demo their new product which helps prepare a visit, and integrates […]

  • BenchSci raises $50m to grow AI-powered R&D platform

    Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical research internationally. The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving […]

  • Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

    Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the advances while ensuring safeguards are in place. As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around […]

  • Enhancing Workflow Automation for Healthcare Professionals

    Hoala Greevy, Founder & CEO of Paubox Like employers in most industries, healthcare organizations are battling to fill open positions amid the current tight labor market. And new reports show a growing wave of nursing shortages. This widespread scarcity of healthcare workers is forcing providers to cope by having practitioners handle tasks like data entry […]

  • 7 Burning Questions from Life Sciences Companies on Using AI Agents

    Troy Lase, Associate Director, Commercial Strategic Planning, IQVIA Richard Marcil, Chief Customer Officer, ConversationHEALTH Each day life science companies respond to numerous medical information inquires – many of which are similar in nature or can be simply addressed. However, as we have seen in the news reports with the Great Resignation and many workers searching […]

  • Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform

    What You Should Know: – Today, Sema4 (Nasdaq: SMFR), a health intelligence company, announced it has signed a definitive agreement to acquire GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million, strengthening its market-leading health intelligence and genomic screening offerings. – The combined company is projected to deliver $350 million in pro forma 2022 […]

  • BioNTech, InstaDeep showcase early warning system for COVID variants

    BioNTech and artificial intelligence startup InstaDeep say they have developed an early warning system that can predict high-risk variants of COVID-19 from their genetic sequences much earlier than with current methods. In testing, the AI was able to correctly identify more than 90% of variants of concern – including the Omicron strain currently spreading around […]

  • Merck backs startup bringing AI to fertility treatment

    It’s no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents. Now, a Canadian biotech aims to tackle that problem though the use of artificial intelligence. Toronto-based Future Fertility has developed an AI called Violet that it says can predict the viability […]

  • Amgen pledges $1.9bn to alliance with AI specialist Generate

    Fresh from a sizeable funding round that raised $370 million, artificial intelligence-based drug discovery firm Generate Biomedicines has just signed its first major partnering deal with Amgen. The machine learning specialist – founded by venture capital firm Flagship Pioneering in 2018 – is getting $50 million upfront to kick off the alliance, with another £370 […]

  • Protai Nabs $8M for AI-Powered Drug Discovery Platform

    What You Should Know: – Protai, a Tel Aviv, Israel-based AI-powered drug discovery startup, today announced its emergence from stealth, along with an $8 million seed financing round co-led by Grove Ventures and Pitango HealthTech. – Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat […]

  • Using Real-World Evidence (RWE) & AI to Enable Better Clinical Care

    Dan Riskin, Founder and CEO at Verantos During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option with the patient at hand is limited by the amount and quality of clinical information that is available. While randomized clinical trials are considered the gold standard for establishing the safety […]

  • 4 ways AI can transform clinical trials

    We cannot simply accept that testing new drugs will continue to be a slow and expensive process. AI has the potential to disrupt the current approach to clinical trials — from patient recruitment to adherence monitoring and data collection – and it is time to seize these opportunities.

  • Using Machine Learning in the Evolving Landscape of Real-World Data

    Zeynep Icten, Ph.D., Director of Data Science Solutions at Panalgo According to the Food and Drug Administration (FDA), the term real-world data (RWD) refers to routinely collected data relating to patient health status and the delivery of healthcare services, and real-world evidence (RWE) is the clinical evidence regarding the usage and potential benefits or risks […]

  • AI specialist Recursion nabs multibillion-dollar Roche partnership

    Roche has formed a decade-long alliance with Recursion Pharma that will focus on using machine learning and “industrialised” drug discovery to find new neuroscience and cancer drugs. The Swiss drugmaker is paying $150 million upfront to kick off the strategic-level partnership, which could cover as many as 40 programmes and could be worth “several billion […]

  • AI-based drug discovery firm BenevolentAI cuts SPAC deal

    UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal. BenevolentAI will merge with Odyssey Acquisition, a SPAC set up by investment bankers Michael and Yoel Zaoui that lists former Sanofi chief executive Olivier Brandicourt […]

  • Nuance Launches Precision Imaging Network for AI-Powered Imaging Insights

    What You Should Know: Nuance launches Precision Imaging Network, a new AI-powered cloud-based platform for radiologists. Nuance® Communications, Inc. (NASDAQ: NUAN) launched the Nuance Precision Imaging Network, an AI-powered cloud platform that delivers patient-specific data and insights from diagnostic imaging into existing clinical and administrative workflows across the healthcare ecosystem. Leveraging the scale of Nuance’s PowerScribe and PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network […]

  • New private equity investment makes Iodine Software the latest healthcare unicorn

    Advent International, a private equity firm, is investing an undisclosed amount into Iodine boosting its valuation beyond $1 billion. The hope is that the company’s AI-powered clinical documentation improvement software can capture a greater share of the market for software products that help hospitals code and bill accurately to receive reimbursement.

  • Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

    Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, […]

  • Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

    Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies. It will take place on June, 20-21, 2022 in Berlin, Germany. One of the major challenges for pharmaceutical executives […]

  • Second FDA okay for Therapixel’s AI-based mammography tool

    France’s Therapixel has secured a second FDA approval for MammoScreen, its artificial intelligence-powered software for detecting cancerous lesions in mammogram images. MammoScreen was approved last year for use alongside conventional digital 2D mammography, and has now been given a green light by the FDA for use with 3D mammograms, also known as digital breast tomosynthesis. […]

  • How IVAs is Helping Care Providers and Patients Deal with Delta Variant

    Callan Schebella, EVP, Product, Five9 Communicating clearly and effectively with patients is a hallmark of good patient care. However, as the Delta Variant defines the next phase of COVID, many healthcare organizations are experiencing a massive surge in patient communication volume. Not only do they need to communicate important updates about the virus, testing, appointments, […]

  • Cardiologs Awarded FDA Clearance for Pediatric Use of Algorithm

    What You Should Know: Cardiologs announced today that the FDA has cleared their algorithm to be used for the pediatric population – younger than 18. Their technology can now analyze ECG readings for atrial arrhythmias across all age groups. Cardiologs, a medical technology company committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud […]

  • Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

    Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. The French drugmaker has been enticed by an artificial intelligence (AI) algorithm developed by Chinese tech giant Baidu, which controls most of China’s search engine traffic and is sometimes referred […]

  • Artificial Intelligence: Healthcare’s Most Powerful Weapon

    Ashley Mehta, CEO & President of Nolij Consulting The Advent of the ‘Digital CRISPR.’ Artificial Intelligence (AI) in the workplace has transformed how healthcare professionals and organizations conduct daily operations. It has also brought significant improvements in patient care and outcomes while moving the needle forward in the prevention and treatment of diseases. In short, […]

  • Generate Bio adds $370M for big push toward programmable protein medicines

    Generate Biomedicines applies artificial intelligence and machine learning to protein analysis, which it uses to program its protein therapies for particular applications. The startup now has $370 million in financing to rapidly scale up operations, with a goal of reaching the clinic within two years.

  • AI specialist Owkin snares $270m alliance with Sanofi in oncology

    Sanofi has made another investment in artificial intelligence, taking a $180 million equity stake in Franco-US startup Owkin with another $90 million in funding for a program to seek out new cancer therapies. The three-year project will focus on four types of cancer, and will deploy Owkin’s predictive biomedical AI models to find new biomarkers […]

  • Respira Launches AI Wearable for Lung Function for COPD, COVID, Asthma

    What You Should Know: – Today, Respira is introducing its AI wearable technology to monitor for certain very serious lung conditions. According to the Institute for Health Metrics and Evaluation, COPD (Chronic Obstructive Pulmonary Disease) and COVID-19 were the 3rd and 4th global causes of death during the height of the pandemic. Asthma, according to […]

  • A preview of MedCity INVEST 2022: A return to in-person conferences

    INVEST, scheduled for March 28-30, 2022 in Chicago, marks a return to in-person events for MedCity News. The conference, held in partnership with Mid-America Healthcare Investors Network, will spotlight healthcare innovation, investment trends, and share insights from healthcare executives.

  • FDA clears GE Healthcare AI algorithm for patient intubation

    An artificial intelligence algorithm developed by GE Healthcare that helps with the placement of endotracheal tubes (ETTs) has been approved by the FDA. The new tool – part of GE’s Critical Care Suite 2.0 – helps bedside staff and radiologists assess patients before intubation – for example prior to ventilation in patients with critical COVID-19 […]

  • AppliedVR Secures $36M to Scale Therapeutic Virtual Reality Platform for Pain Management

    What You Should Know: – AppliedVR, a Los Angeles, CA-based company advancing the next generation of immersive therapeutics, today announced $36 million in series B funding, bringing its total funding to $71M. The round, which included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures, set up AppliedVR for rapid growth as […]

  • Rad AI Nabs $25M to Automate Radiology Impressions, Save Time, Reduce Burnout, Improve Patient Care

    What You Should Know: – Rad AI, a Berkely, CA-based radiologist-led AI company, today announced $25M in Series A funding led by ARTIS Ventures with participation by several existing investors, including OCV Partners, Kickstart Fund, and Gradient Ventures (Google’s AI-focused fund). – Rad AI Omni automatically generates a customized impression from the findings and clinical indication dictated by the […]

  • Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment

    Thomas Bock, M.D., Chief Executive Officer of Notable What You Should Know: – Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes. – Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify […]

  • Reshaping Imaging: 4 Areas Enhancing Provider Workflows & Patient Care

    Paul Shumway, co-founder at Novarad Ever since Wilhelm Roentgen created the first X-ray image in 1895, few technologies have had more influence on medicine than those related to clinical imaging. It’s pretty remarkable if we compare the MRI, CT, and X-ray technologies of even just 20 years ago with those of today. Rapid innovation is […]

  • CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies

    Arbor Biotechnologies raised new cash to keep up the pace in the chase for new genetic medicines. The MIT spinout applies artificial intelligence and machine learning to discover CRISPR enzymes applicable for gene-editing therapies; the Series B financing comes as programs in liver and central nervous system disorders move closer to human testing.

  • Sirona Medical Secures $40M for Cloud-Native Radiology Operating System

    What You Should Know: – Sirona Medical, a San Francisco, CA-based cloud software company for radiologists taking on legacy technology, announced $40 Million in Series B funding led by GreatPoint Ventures and joined by Rose Park Advisors and Avidity Partners, with additional participation from previous investors including 8VC and Global Founders Capital. – Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native […]

  • Caption Health, Ultromics Partner for AI-Powered Heart Disease Detection

    What You Should Know: – Caption Health and Oxford University spin-out Ultromics have teamed up to empower a broader set of healthcare providers and put heart disease detection and management tools in more hands. This is a second strategic partnership that Caption Health secured in the last three months to enable earlier disease detection and […]

  • Alphabet’s DeepMind forms AI drug discovery unit Isomorphic Labs

    Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into DeepMind’s AI-powered AlphaFold engine that last year became the first to solve the tricky problem of predicting protein folding, but will operate separately. It […]

  • Mount Sinai Uses Machine Learning to Improve Postpartum Hemorrhage Risk Prediction

    What You Should Know: – Sema4, an AI-driven genomic and clinical data intelligence platform company, recently published two studies demonstrating the utility of machine learning to predict clinical outcomes for postpartum hemorrhage (PPH). The studies, which will appear in a special “Informatics for Sex- and Gender-Related Health” print issue of the Journal of the American Medical […]

  • Collective Medical, Nuance Launches PowerShare to Provide ED Physicians Real-Time Notifications

    What You Should Know: – Today, Collective Medical, a PointClickCare Company, was chosen for a collaboration with Nuance with the launch of Naunce PowerShare Image Aware.  – The collaboration will provide emergency department (ED) physicians with real-time notifications of a patient’s prior radiology studies within existing clinical workflows. Point-of-care access to previous diagnostic images reduces unnecessary imaging, healthcare […]

  • Notable Secures $100M to Expand Intelligent Automation in Healthcare

    What You Should Know: – Notable, a San Mateo, CA-based leader in healthcare intelligent automation, today announced it has raised $100M in Series B funding led by ICONIQ Growth, including participation by Greylock, F-Prime Capital, and Oak HC/FT to accelerate growth and innovation within the healthcare industry.  – The company plans to use the new round […]

  • U of Florida to Deploy DreaMed AI Solution for Type 2 Diabetes

    What You Should Know: – DreaMed Diabetes AI, developer of the AI-powered Advisor Pro Clinical Decision Support System and expert-care platform for diabetes, announced today the expansion of its commercial relationship with the Pediatric Endocrinology Clinic at the University of Florida in Gainesville. – The clinic will begin using the Advisor Pro Decision-Support System for […]

  • Personalized Screening is Key to Breast Imaging AI Market Reaching $205M by 2025

    Dr. Sanjay M. Parekh Ph.D. , Sr Market Analyst at Signify Research Ltd. As October draws to a close, so does Breast Cancer Awareness Month (BCAM), or National Breast Cancer Awareness Month (NBCAM) as it is known in the US. Breast imaging AI vendors are heavily promoting this initiative to raise awareness of the disease […]

  • Improving automation in healthcare CX: insights and examples

    There are a few things healthcare organizations need to do automated self-service well: a cloud-based communication platform built on composable infrastructure, reliable EHR data, and a way to segment this data to create experiences that matter.

  • How Healthcare NLP has Evolved from 2020 to 2021

    David Talby, CTO, John Snow Labs Few industries have embraced natural language processing (NLP) as openly as healthcare. With the ability to identify new variants of COVID-19 and help speed up clinical trials for the vaccine, the pandemic is just one example of what NLP is capable of achieving. And while new research points to […]

  • The role of AI in advancing neuromodulation treatment for epilepsy

    Vagus nerve stimulation devices still have a long way to go, but the therapeutic potential of the vagus nerve, the advent of AI and machine learning in healthcare and the opportunity to establish truly personalized digital medicine are enough to warrant further exploration into VNS.

  • It’s Time More Healthcare Companies Break Through Data Silos

    Derik Ciccarelli, a Healthcare Fraud Analyst at Codoxo Unifying health records remains a challenge, but the benefits of integrating disparate data could transform the industry Healthcare payers, providers and agencies have traditionally struggled with unifying health records, but no longer is that a viable reason to put off what can be achieved today. It’s time […]

  • Northwell Health, Aegis team up to launch AI-focused joint venture

    The health system and startup studio’s new joint venture will develop and launch companies that use artificial intelligence to address healthcare problems, including disparities in care. The venture will combine Northwell’s clinical expertise and patient data with Aegis’ data scientists and commercialization capabilities.

  • Arine Raises $11M to Scale AI-Driven Medication Optimization Platform

    What You Should Know: – Arine, a San Francisco-based AI-driven platform that optimizes medication management, reduces costs and improves outcomes for health plans and providers today announced that it closed $11 million in an oversubscribed Series A round co-led by 111° West Capital Partners and Katalyst Ventures, with strategic investments from Magellan Health Inc. and SCAN […]

  • Healthcare Data & Analytics Platforms: Shifting from Siloed Capabilities

    Bradley Hunter, Research Director at KLAS Research Ryan Pretnik, Research Director at KLAS Research Lois Krotz, Research Director at KLAS Research Historically, analytics capabilities for healthcare organizations have been offered in siloed solutions. These solutions provide quick insights but not the longitudinal patient, financial, and operational views organizations need to truly move the needle in […]

  • CommonSpirit, Vital Expand Partnership After Successful Pilot to Improve Patient Experience in ED & Patient Care Delivery

    What You Should Know: – Today at HLTH 2021, CommonSpiritHealth announced the results of its pilot with Vital, the artificial intelligence (AI)-powered software improving patient experience and follow-up visit loyalty in hospital emergency departments (ED) and inpatient stays. Vital’s digital tool, ERAdvisor, helps keep patients informed and in control of their visit by providing real-time […]

  • HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps

    What You Should Know:  – Ibex Medical Analytics, the pioneer in AI-based cancer diagnostics, today announced that it has signed a deal with Roche, the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to […]

  • HLTH21: Olive Launches Universal Marketplace for Digital Healthcare Solutions

    What You Should Know:  – Today at HLTH, $4B healthcare automation company Olive announced the launch of The Library, a healthcare solution marketplace that will reduce the burden for early-stage developers as they bring innovative new technology solutions to patients. – This new marketplace enables Olive’s partners — ranging from individual developers to large enterprise […]

  • Four big pharma companies team up in AI initiative focused on drug R&D

    A new startup initiative in Israel aims to create and invest in startups that use artificial intelligence to address challenges in drug discovery and development. Called AION Labs, this innovation lab stems from an economic development effort from the Israeli government and will have contributions from AstraZeneca, Merck, Pfizer and Teva Pharmaceutical.

  • Can Predictive AI Fully Inform Patient Care Decisions?

    Laura Coughlin, RN, BSN, MBA VP, Clinical Innovation and Development, Change Healthcare In recent years, the healthcare industry has fully embraced the potential for artificial intelligence (AI) to transform healthcare practice and delivery. From the advent of big data to the arrival of EHRs, the industry is familiar with the hype that accompanies technology advancements. […]

  • University of Michigan Health-West Deploys Nuance Dragon Ambient eXperience

    What You Should Know:  – Today, Nuance and the University of Michigan Health-West (UMHW), a 208-bed hospital in Wyoming, MI, announced that UMHW has expanded its adoption of Nuance’s pioneering ambient clinical intelligence technology, Dragon Ambient eXperience – a solution that empowers physicians to reduce administrative workloads and focus on patient care with clinical documentation […]

  • Get Ready for Deepfakes

    By KIM BELLARD The Tom Cruise TikTok deepfakes last spring didn’t spur me into writing about deepfakes, not even when Justin Bieber fell so hard for them that he challenged the deepfake to a fight.  When 60 Minutes covered the topic last night though, I figured I’d best get to it before I missed this […]

  • Lessons Learned: The Impact of COVID-19 on Infusion Center Scheduling

    Ashley Joseph, VP, Client Services – Infusion at LeanTaaS Over the past year, COVID-19 brought new stresses to hospital scheduling, given limited resources, physician availability, staffing challenges and physical materials. Beyond the obvious struggles with ICU capacity, COVID-19 also put a heavy strain on every step of the chemotherapy patient journey – from navigating new […]

  • Mount Sinai Launches First-Ever Dept. of Artificial Intelligence and Human Health

    What You Should Know: – The Icahn School of Medicine at Mount Sinai has launched its first-ever department dedicated to advancing artificial intelligence (AI) to transform healthcare. The Department of Artificial Intelligence and Human Health mission is to lead the artificial intelligence-driven transformation of health care through innovative research, apply that knowledge to treatment in […]

  • Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs

    Neumora Therapeutics unveiled $500 million in capital and a research partnership with Amgen. The startup analyzes neurological data to inform its drug research and development; President and Chief Operating Officer Lori Lyons-Williams said researching psychiatric drugs and neurodegenerative drugs within the same company allows brain insights from one area to inform the other.

  • SOM’s AI-discovered drug shows promise in Huntington’s disease

    A drug originally developed for high blood pressure could find a new use in the treatment of Huntington’s disease, thanks to an artificial intelligence-based drug discovery programme at Spain’s SOM Biotech. SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington’s disease, improving the involuntary, jerky movements known as chorea […]

  • AI specialist Exscientia raises $510m in upsized IPO, placing

    Exscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in funding from investors keen to back its platform. The final numbers are now in from its recently announced initial public offering on the US Nasdaq, and the numbers are impressive, swelling from an initially forecast $304 million […]

  • AI powered and now publicly traded, Exscientia adds $464M to fuel drug R&D

    Exscientia’s IPO and private placement raised $464 million to support its artificial intelligence-based approach to discovering and developing new drugs. In addition to partnerships with pharmaceutical companies, an alliance with the Bill & Melinda Gates Foundation is focused on developing antiviral drugs for future pandemics.

  • UltraSight, GE Healthcare Partner to Bring Wireless Cardiac Point of Care Ultrasound

    What You Should Know:  – Today UltraSight, a digital health pioneer, announced a new partnership with GE Healthcare that will bring AI-assisted wireless, cardiac ultrasound to space. They will conduct a study aboard the upcoming Axiom ‘Rakia’ space mission and record images of an astronaut’s heart in microgravity, using UltraSight’s real-time AI guidance software and […]

  • Learning from Financial Fraud Detection to Tackle Opioid Abuse Amid COVID-19

    Dr. Gidi Stein, MD, Ph.D., Co-Founder and CEO of MedAware Despite falling from its prominent place in the headlines, America’s opioid crisis is still raging. Anxiety, stress, depression, and isolation caused by the pandemic have contributed to substance use disorders. At the same time, the Drug Enforcement Administration has loosened prescribing restrictions, including waiving the […]

  • Vital Raises $15M to Expand AI-Powered Emergency Department Platform

    What You Should Know: – Vital, an Atlanta-based artificial intelligence (AI)-powered solution improving patient experience and follow-up visit loyalty in hospital emergency departments (ED) and into inpatient stays, has secured $15M in Series A funding led by Transformation Capital, with a strategic health system joining the round alongside existing investors First Round Capital and Threshold […]

  • P360 Boosts ZING SMS Communication Module with Multimodal Enterprise-Grade Features

    Innovative new UCaaS platform powers sales teams with compliant SMS text messaging, call triggering, asset delivery, activity tracking and more P360, a leading developer of technology for life sciences companies, today announced that its ZING Communication Module has been enhanced with several new enterprise-grade unified communication features. Not only does the ZING unified communications as […]

  • How Machine Learning Is Helping Consumers Take Action on Their Health

    Craig Wigginton, Chief Technology Officer at Icario For years machine learning (ML) has been touted as a way for health plans to leverage the mounds of data they collect on their members, but practical use cases remain relatively uncommon. For some, the perception may be that ML is a futuristic and somewhat impersonal way to […]

  • YonaLink, TrialJectory get $1m grant for patient recruitment tool

    Two digital health companies – YonaLink and TrialJectory – have received a grant to develop a tool designed to make it easier and quicker to enrol patients into clinical trials. The grant from the Israel-US Binational Industrial Research and Development (BIRD) Foundation will go towards the further development of the platform, which automates the conduct […]

  • Spotting and rooting out bias in AI algorithms for healthcare

    Algorithms are everywhere and so are the biases behind them. As algorithms find greater use in healthcare, a panel at MedCity News’ INVEST Digital Health virtual conference addressed how and why algorithms are biased, how that bias affects clinical care, and some possible solutions to bias.

  • FDA clears AI-powered prostate cancer detection software

    Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA. The software – called Paige Prostate – is the first artificial intelligence-based to be approved by the FDA for this purpose, according to the US regulator. It is used to screen for signs of cancer […]

  • RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare

    RwHealth, the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies.   RwHealth’s unique Data Science Platform combines Artificial Intelligence (AI), Machine Learning and Data Science to give healthcare providers […]

  • Clinicians Believe Telehealth Will Make Up Majority of Future Patient Care, Report Finds

    What You Should Know: – 76% of patient-facing clinicians believe telehealth will make up a majority of patient care in the near future, according to key findings from Hewlett Packard Enterprise’s (HPE) first-ever multi-country Future of Healthcare” Survey.  The new report not only found healthcare clinicians and IT Decision Makers (ITDMs) optimistic about the future […]

  • Healthcare Automation Most Urgent Need to Improve Patient Care, Report Finds

    What You Should Know: Half of the healthcare administrative staff report seeing an increase in the amount of manual data entry in the past 12 months — and 92% of clinicians agree that too much time spent on administrative tasks is a major contributor to healthcare worker burnout. This and other findings are revealed in […]

  • Leveraging Technology to Optimize Staffing Shortages Post-Pandemic

    Bryan Dickerson, Sr. Director of Healthcare Workforce Solutions at Hospital IQ Chronic understaffing and nurse burnout are two of the greatest and long-standing challenges within the healthcare industry. As a result of the pandemic, these challenges were acknowledged more than ever before. Pre-pandemic research highlighted the fact that the nurse vacancy rate in the United […]

  • Sorcero Raises $10M for AI-Powered Medical Language Intelligence Platform

    What You Should Know: – Sorcero, a provider of medical and technical Language Intelligence (LI), today announced the close of a $10M Series A financing round led by CityRock Venture Partners and Harmonix Fund. The round also included participation from Rackhouse, Mighty Capital, and Leawood VC, and joining previous investors, Castor Ventures and Worldquant Ventures, […]

  • Caresyntax Raises Additional $30M for Digital Surgery Platform

    – Caresyntax, a digital surgery platform, today announced a $30M extension to its Series C funding round included participation from BlackRock, ProAssurance, and Harmonix. In addition to existing investors such as the Relyens Group and IPF Partners. This extension brings the total Series C funding to $130M. – Caresyntax’s digital surgery platform uses proprietary software […]

  • Flywheel raises $22M, buys competitor

    After closing a series C round led by 8VC, Flywheel used a portion of the funds to acquire St. Louis-based Radiologics. Both have platforms to help researchers process medical imaging data. 

  • Swift Medical Launches AI Digital Wound App to Support Clinical Trials

    What You Should Know: Global digital wound care provider Swift Medical, today announced the launch of a new application specifically designed to help pharma and med device researchers conduct decentralized clinical trials. Since patients are now doing more trials at home, study coordinators have had trouble tracking skin side effects remotely — or trusting patients […]

  • Edifecs Acquires Talix to Expand Risk Adjustment Solution

    What You Should Know: – Edifecs, a global health IT provider announced it is acquiring Talix, a SaaS IT company, to expand Edifecs’ reach in the encounter management and risk adjustment space. Financial details of the acquisition were not disclosed. – The integration of Edifecs’ and Talix’s technologies will create an expanded risk adjustment solution […]

  • AI aims to prevent unneeded treatment for deep vein thrombosis

    Researchers in the UK are working on an artificial intelligence (AI) algorithm to help diagnose deep vein thrombosis (DVT) from ultrasound images – and potentially prevent patients from receiving drugs unnecessarily. The team from Oxford University, Imperial College London and the University of Sheffield are working with German tech company ThinkSono on the smartphone-based app, […]

  • Coalition formed to represent patient interests in digital health

    Not enough is being done to ensure that patient voices are included in policymaking around digital health, says a new patient organisation in the UK, which aims to set that situation right. The Patient Coalition for AI, Data and Digital Tech in Health has brought together members of patient organisations, medical colleges and health charities […]

  • AI as Business Leverage in Pharma & Life Sciences

    If there was an AI solution in the Life Sciences field, able to represent a real opportunity in terms of Customer Engagement and Digital Transformation, and if some of the most important players in the industry already had it, would you like to have the opportunity to listen to them?    This and other trend […]

  • Evidence lacking for AI-based breast cancer screening  

    A review of 12 studies about AI systems used to screen patients for breast cancer found that they lacked evidence to prove that they would work well in a clinical setting. Researchers highlighted concerns about study quality, including the fact that all of the studies were retrospective and many of them had a high risk […]

  • Eleos Health Raises $6M to Expand VoiceAI-Powered Behavioral Health

    What You Should Know: – Eleos Health, a digital health startup transforming behavioral healthcare with voice-based AI insights, today announced the close of $6M in seed funding to develop and launch their new category of automated health tech solutions that accelerate clinicians’ decision making led by aMoon Fund with participation from lool ventures, who led […]

  • Chatbots in Healthcare: A More Humanized, Patient-Oriented Approach

    Bent Philipson, Founder of Philosophy Care The adoption of chatbots and virtual assistants, coupled with the integration of artificial intelligence and machine learning technology, has revolutionized the healthcare industry. In many ways, chatbots have become ubiquitous, providing a more optimized user experience through digital means. The healthcare industry has already benefited immensely from this technology, […]

  • Corti Receives $27M to Expand AI-Powered Patient Consultations Platform

    What You Should Know: –, a Copenhagen, Denmark-based AI-powered patient consultations platform today announced it has raised $27M in Series A funding led by Vaekstfonden, the Danish Growth Fund and Chr. Augustinus Fabrik, who joins existing investors Hearcore, Id Invest, and byFounders. – Founded by  Lars Maaløe and Andreas Cleve in 2016, Corti provides […]

  • Cedars-Sinai Cancer Launches ‘Molecular Twin’ Initiative for Precision Cancer Treatment

    What You Should Know: – Cedars-Sinai Cancer and Tempus, a provider of artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients’ DNA, RNA, protein and other information to help identify the most effective approach to each individual’s disease. […]

  • Startup A-Alpha Bio sets out to solve a major protein problem facing big pharma

    A-Alpha Bio’s technology analyzes millions of protein-protein interactions simultaneously, a capability that speeds up drug discovery research. Biotech industry partners are already using the technology and now with $20 million in Series A funding, the startup plans to build machine-learning capabilities to crunch the data produced by all of those protein interactions.

  • AI ‘could help diagnose lung cancer a year earlier’

    An artificial intelligence algorithm was able to detect signs of lung cancer on CT scans a year earlier than with traditional methods, according to a new study. CT (computed tomography) scans are already used to spot signs of lung tumours, followed by a biopsy or surgery to confirm whether the tumour is malignant, according to […]

  • Stryker Acquires Med Device Company Gauss Surgical

    What You Should Know: – Stryker today announced the acquisition of Gauss Surgical, a Menlo Park, CA-based medical device company that has developed Triton™, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Financial details of the acquisition were not disclosed. – Triton combines the power of A.I. with the simplicity of […]

  • Startup Modulus embraces AI to design better NK cell therapies for cancer

    Modulus Therapeutics recently emerged from stealth with technology from various disciplines and seed funding that the startup is using to develop better cell therapies. Natural killer cells directed against breast cancer is Modulus’s initial focus, but the startup says its approach can apply to multiple types of immune cells and multiple types of cancer.

  • AI could be used to guide drug therapy for heart failure

    UK researchers have used artificial intelligence (AI) to develop a way to identify patients with heart failure who would benefit from treatment with beta blockers, by interrogating data from nine landmark clinical trials. The study applied machine learning to trial data involving 15,659 patients who were being treated for heart failure with reduced ejection fraction […]

  • AI breast cancer screening ‘not accurate enough to replace humans’

    There is not enough evidence yet to allow artificial intelligence based breast cancer detection to be fully integrated into screening services, says a UK study. The analysis of a dozen studies of AI-powered image recognition software for breast cancer screening – published in the British Medical Journal – has found that the technology isn’t yet […]

  • Italian ‘chatbot’ predicted COVID-19 spikes, says study

    An online tool used by people in Italy to manage their potential exposure to COVID-19 using a simple chat interface has shown that it can spot emerging trends days ahead of the national surveillance system. The decision support system (DSS) – developed by Italian digital health startup Paginemediche – provided a way for people to […]

  • Clinical Trials: 4 Strategies to Maximize Patients Referrals

    Jai Singh, SVP of Growth at Reify Health Clinical trials were front and center in 2020, as pharma companies raced to develop and prove the safety and efficacy of their COVID-19 vaccines. Despite this increased awareness, many potential participants and referring clinicians remain unaware of available trials and how to become involved. This negatively impacts […]

  • Real-world study suggest AI may improve atrial fibrillation screening

    An artificial intelligence algorithm already shown to be able to detect atrial fibrillation (AF) in clinical testing has also shown its worth in a real-world setting, according to its developers. The AI – developed by the Bristol Myers Squibb-Pfizer Alliance on cardiovascular disease – was developed using machine learning from a UK dataset of almost […]

  • Ellipsis Health Secures $26M to Power AI-Powered Voice Biomarker for Mental Health

    What You Should Know: – Ellipsis Health, a San Francisco-based pioneer of the first voice vital sign to quantify and manage depression and anxiety at scale has raised $26M in Series A funding led by SJF Ventures with participation from several investors. The Series A investment round brings Ellipsis Health’s total funding to $31 million. […]

  • Osso VR Launches VR-based Surgical Proficiency Assessment Tool

    What You Should Know: – Osso VR, a San Francisco, CA-based virtual reality-based surgical training company, today announced the launch the of its VR-based multimodal assessment experiences. In addition to adding this capability within its platform, Osso’s platform has also launched in multiple new languages in addition to English, including Japanese, Spanish, German and French […]

  • How AI Helped Companies Survive COVID-19: 5 Tips for Resilience

    Tim Lawes, Sr. Manager for Solutions Consulting at Symphony SummitAI As the coronavirus pandemic transformed workplaces and workflows, it cast a spotlight on service management and resilient systems. Here are key lessons in how AI can improve your company’s operations moving forward.  The coronavirus pandemic inaugurated a revolution in the workplace as millions of employees […]

  • Cooper University, Nuance Expand Dragon Ambient eXperience Deployment to 475 Physicians

    What You Should Know: – Nuance Communications and Cooper University Health Care announced a strategic collaboration to expand Cooper’s deployment of the Nuance Dragon Ambient Experience (DAX) to 475 physicians based on previous deployment success. This ambient clinical intelligence solution will expand upon Cooper’s ability to enhance patient experiences, expand access to care, and advance […]

  • Sanas’ Accent-Matching Solution for BPOs Launches with $6M

    What You Should Know: – Today – which has been operating under stealth for a couple of years – is launching and announcing seed funding. Their AI platform for audio matches the accent of the person you’re speaking with to yours with no perceptible lag time. Top venture funds investing in the company’s $5.5 […]

  • A biotech startup’s hunt for elusive disease targets scores $60M for drug R&D

    Atavistik Bio is one of several companies discovering and developing drugs that work by allostery, binding to less obvious sites of a target protein. Acting CEO John Josey said the startup aims to stand apart with its focus on understanding metabolic interactions, a path less trodden by others in allosteric drug discovery.

  • Jasper Health Integrates BioIntelliSense’s RPM and COVID-19 Screening Solution for Members

    What You Should Know:  – Today, BioIntelliSense announced it has formed a strategic collaboration with Jasper Health, an emerging leader of digital engagement for people diagnosed with cancer. – As part of the strategic collaboration, Jasper Health will integrate the BioIntelliSense FDA-cleared BioSticker and medical grade BioButton® wearable devices as part of its remote member […]

  • Olive Launches In-House Venture Studio for Digital Health Startups

    Olive Launches In-House Venture Studio for Digital Health Startups What You Should Know:  – Olive, the $4B healthcare automation company, today announced Olive Ventures, a new in-house venture studio that works hand-in-hand with early-stage entrepreneurs to create digital health companies through Olive’s platform.  – Olive Ventures offers visionaries a secure, compliant tech environment (i.e. Olive’s […]

  • J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech

    Three years ago, Johnson & Johnson set up a wide-ranging initiative with Boston University to try to improve lung cancer survival rates through prevention and early intervention. Now, its calling on artificial intelligence specialist Optellum to help with that effort. UK-based Optellum has developed an AI-powered clinical decision support – called Virtual Nodule Clinic – […]

  • Engagement, Interoperability, and the Future of the Healthcare Tech Stack

    Jeff Fuller, Vice President, Analytics Solutions at CipherHealth For all of the advanced clinical technology hospitals across the country leverage to stay on the bleeding edge of innovative patient care, healthcare, as an industry, has been extremely slow to adapt when it comes to implementing modern technology to improve everyday processes—both inside and outside clinical […]

  • Connect America Acquires Remote Patient Monitoring Platform 100Plus

    What You Should Know: – Connect America LLC, a provider of digital health and connected care for seniors and vulnerable populations, today announced it has signed a definitive agreement to acquire 100Plus, the remote patient monitoring (RPM) platform that uses artificial intelligence (AI).  – Connect America, a portfolio company of Detroit-based Rockbridge Growth Equity, is […]

  • I am Dr. Groot

    By KIM BELLARD The healthcare world is abuzz with Dr. David Feinberg’s departure from Google Health – another tech giant is shocked to find healthcare was so complicated! – while one of those tech giants (Amazon) not only just surpassed Walmart in consumer spending but also is now planning to build its own department stores.  […]

  • Dosis Expands Dosing Platform to Personalize Anemia Management

    What You Should Know: – Dosis, the AI-powered precision dosing platform on a mission to transform healthcare, has announced the release of its Strategic Iron Advisor (SIA) tool, the first precision dosing tool on the market for intravenous iron.  – SIA is a sub-module that works with Dosis’s existing anemia tool, Strategic Anemia Advisor (SAA), […]

  • Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

    What You Should Know: – Optellum, a lung-health medtech startup that is pioneering the use of AI to improve diagnostic accuracy and clinical decision-making announce a strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative. This announcement accelerates Optellum’s market entry, building on its FDA clearance earlier this year and deployments underway at hospitals in the USA and ongoing clinical trials […]

  • Provider Adoption of Automated Revenue Cycle Operations On The Rise

    What You Should Know: – 78 percent of health systems are currently using or are in the process of implementing automation in their revenue cycle operations, according to recent survey results from AKASA, a South San Francisco-based revenue cycle management automation company. The key findings signal automation in healthcare is no longer an emerging trend […]

  • BMS buys into AI-designed immune drug from Exscientia

    Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part of their $1.2 billion alliance. The unnamed drug candidate acts on an immunological kinase enzyme, which has proven hard to target using conventional drug discovery techniques because challenges […]

  • Sentara Healthcare Taps Sensyne to Deploy Clinical Algorithms for CKD & CHF

    What You Should Know: – Sentara Healthcare, a health system in NC and VA, just partnered with Sensyne Health to drive clinical research with ethical AI. – As part of a collaboration agreement, Sentara also becomes the first of several U.S. health systems that will partner with Sensyne to implement new clinical algorithms to support […]

  • Raises $34M to Expand Healthcare Data Science Platform

    What You Should Know: –, an Austin, TX-based healthcare data science platform, today announced it has raised $34 million in Series B financing led by Telstra Ventures with participation from Breyer Capital, Greycroft Ventures, .406 Ventures, and Healthfirst. Notable angel investors Adam Boehler (former director of CMMI & CEO of Landmark Health) and Sam Palmisano […]

  • Global regulators seek permanent working group on AI

    Rapid advances in the use of artificial intelligence (AI) in healthcare and medicines development are at risk of outstripping current regulatory frameworks, according to a new report. The International Coalition of Medicines Regulatory Authorities (ICMRA) has recommended that a new permanent working group be set up to keep tabs on the use of AI and […]

  • Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians

    What You Should Know: – Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management. – DUO is a pocket-sized cardiac examination system for clinicians used […]

  • AI firm XtalPi swells its coffers with another $400m financing

    Artificial intelligence (AI) specialist XtalPi has chalked up a second big financing in the space of a year, raising $400 million and taking its valuation to around $2 billion. Founded several years ago by a team of MIT researchers and previously backed by Google, XtalPi deploys AI to a range of drug discovery and development […]

  • How AI is Enabling Next-Generation Insights from Biomedical Data

    Alastair Blake, MD – VP of Clinical & Commercial Partnerships at nference COVID-19 caught the world off-guard, sending governments, populations, and the entire healthcare community — physicians, nurses, scientists, pharmaceutical companies, and medical device manufacturers included — scrambling to discover and deliver rapid solutions as millions of lives hanging in the balance.  The heroic efforts […]

  • Olive Selects AWS as Its Preferred Cloud Provider to Create the Internet of Healthcare

    What You Should Know: – Olive, the AI healthcare company, announced today the adoption of Amazon Web Services, Inc. (AWS) as its preferred cloud provider, now leveraging AWS’s computing capabilities to improve healthcare efficiency and reduce costs for patients and organizations. – Olive’s workflow automation solution will run on AWS to connect the disparate systems […]

  • Kareo Acquires RPA-Powered Medical Billing Provider PatientlySpeaking

    What You Should Know: – Kareo, a provider of cloud-based clinical and business management software solutions for independent healthcare practices and billing companies, today announced the acquisition of PatientlySpeaking, a process automation technology company for billing companies and medical practices. – Together with Kareo’s intuitive billing platform, PatientlySpeaking provides an integrated data connection for billing […]

  • Nanox Acquires Medical Imaging Platform Zebra Medical Vision for $200M

    What You Should Know: –   Nanox, the innovative medical imaging company, today announced the acquisition of Zebra Medical Vision, the deep-learning medical imaging analytics company. – In a deal valued at up to $200M, the medical imaging pioneers will leverage Zebra-Med’s industry-leading team, cutting-edge AI technology, and cloud capabilities, and unprecedented regulatory framework to form […]

  • Sensyne, Oxford University deploy AI to find asthma targets

    Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma. It’s estimated that almost one in five people with asthma find it difficult to control symptoms using current therapies, while around 4% have particularly severe forms that puts them […]

  • Cambridge team says AI could diagnose dementia with one scan

    Researchers at Cambridge University in the UK are trialling an artificial intelligence system that they think could spot the signs of dementia after a single brain scan. The team – led by Prof Zoe Kourtzi of the university and Alan Turing Institute – told the BBC that the AI could make it possible to start […]

  • GE Healthcare Unveils AI-Enabled, Cloud Imaging Solution

    What You Should Know: – GE Healthcare unveils its next-generation, cloud-based Picture Archive and Communication System (PACS) designed to address the acute shortage of radiologists and growing demand for imaging scans has put radiology departments under increased strain. Edison True PACS is a transformative system, offering AI-enabled decision support to help radiologists adapt to higher […]

  • Rad AI Startup Sirona Medical Emerges from Stealth with $22.5M, Partnerships

    What You Should Know: – Sirona Medical, a San Francisco, CA-based company founded on a deep understanding of both the practice and business of radiology, today announced partnerships with radiology practices across the country to develop and bring to market its novel radiology operating system (RadOS). – Sirona’s collaboration with five leading national practices including […]

  • Eli Lilly joins $30M Series A financing for startup bringing AI analysis to endoscopy

    The artificial intelligence-based technology of Iterative Scopes brings computer vision analysis to endoscopic images. The startup’s technology was initially developed to assist gastroenterologists in finding pre-cancerous polyps but CEO and founder Jonathan Ng said it’s also finding additional use helping pharmaceutical companies identify patients for clinical trials.

  • Risk Mitigation: Strengthening Trust in AI for Healthcare

    Joachim Roski, Principal at Booz Allen Hamilton Kathleen Featheringham, Principal at Booz Allen Hamilton Better clinical decision support, population health interventions, patient self-care, and research – these are just a few of the promising use cases of artificial intelligence (AI). In addition to its benefits, AI can introduce risks that could potentially undermine trust in […]

  • Abbott bags FDA okay for AI-based heart imaging software

    The FDA has approved an artificial intelligence-based imaging software developed by Abbott that is used to help physicians carry out procedures like implanting stents to open up narrowed blood vessels in the heart.  Abbott‘s Ultreon software is billed as a first-of-its-kind platform that is designed to be used with optical coherence tomography (OCT), an imaging […]

  • Medtronic Awarded FDA Clearance for 2 AI Algorithms for Cardiac Monitoring

    What You Should Know: – Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021. – AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event […]

  • AI-driven Deep Genomics gets $180M to turn biology into informational medicines

    Softbank led the Series C round of funding for Deep Genomics, a startup that applies its artificial intelligence technology to all aspects of discovering and developing new drugs. The Deep Genomics platform has yielded 10 programs; CEO Brendan Frey aims to advance four of them to the clinic in two years, all while tripling the […]

  • Google’s DeepMind puts human proteome online for free

    The most complete database of protein structures ever assembled, developed with the help of Google’s artificial intelligence unit DeepMind, has been made freely available to researchers around the world. DeepMind partnered with the European Molecular Biology Laboratory (EMBL) to come up with the AlphaFold database, which predicts the three-dimensional structures of the human proteome – […]

  • Sema4 goes public via SPAC merger

    With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.

  • Crowdsourced science refines AI prediction of clinical trial outcomes

    Think of the R&D dollars that could be saved if artificial intelligence (AI) modelling could tell you at an early stage whether a drug was likely to succeed in clinical trials, and ultimately reach the market. In 2019, a team at Massachusetts Institute of Technology (MIT) in the US came up with just such a […]

  • Hospital precision dosing is ramping up

    Artificial intelligence and predictive models are making it increasingly easier for physicians and pharmacists to select the right treatment for the right patient at the right time.

  • INVEST Precision Medicine winner spotlight: Nia Therapeutics

    The FDA has yet to approve a therapy for memory loss. Nia Therapeutics is developing a medical device that stimulates the brain to bring it back to a “good memory state,” and it was judged the winner in the life sciences track of the INVEST Precision Medicine Pitch Perfect Competition.

  • AI-driven ‘clock’ predicts aging-related illness and mortality

    Scientists in the US have developed an artificial intelligence-powered ‘clock’ that can estimate a person’s chance of developing an illness or dying based on the pattern of cytokines in their blood. The “inflammatory age” or iAge clock – described in the journal Nature Aging – uses a snapshot of the level of chronic inflammation in […]

  • Israeli Startup Aidoc Raises $65M for AI-Powered Medical Imaging Platform

    What You Should Know: –  Aidoc, a Tel Aviv-based provider of artificial intelligence (AI) solutions for medical imaging, announced it has raised $65M in Series C funding led by General Catalyst, bringing its total funding to $140M. – This Series C round comes on the heels of a surge in demand for Aidoc’s AI-driven solutions, […]

  • Taking steps towards a data-driven future for health and social care

    A new policy paper promises to make it easier for innovators and developers to build and deploy tech and AI solution. So, will it help make the vision of a data-driven health service a reality? COVID-19 “revolutionised” the health and care data space, and we have a duty to apply what we have learnt to […]

  • Provider-owned Innovation Lab partners with Olive to build automation tools

    Innovation Lab, an incubator owned by six nonprofit health systems, is joining forces with Olive to co-develop technology that will automate operational and clinical workflows. The companies will leverage Olive’s AI platform, as well as Innovation Lab’s frontline access to its health system owners.

  • Gates Foundation backs COVID R&D at AI firm Exscientia

    Artificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an award by the Bill & Melinda Gates Foundation.  The $1.5 million grant will be used to develop a new class of small-molecule inhibitors of Mpro , a protease enzyme essential for the replication of the SARS-CoV-2 virus. […]

  • Zebra-Med Becomes First Company to Receive AI CPT Code for Radiology

    What You Should Know: – Zebra Medical Vision announces it has received the first-ever AI CPT code for radiology, for its VCF detection from CT scans for Population Health, setting a new standard for CPT codes in imaging AI, as the company has successfully done with FDA clearances for its algorithms.  – The new CPT […]

  • How chatbots can help us beat Covid-19

    Where chatbots really excel is in rapidly delivering reliable content in response to the recipient’s actual needs, questions, or concerns. That allows AI tools to serve as a bridge between vaccine manufacturers, regulators, public health officials, healthcare providers on the one hand and patients on the other.

  • NVIDIA Launches UK’s Fastest AI Supercomputer for Healthcare Research

    What You Should Know: – NVIDIA launched the UK’s fastest supercomputer — Cambridge-1, the world’s first collaborative, industry-wide system dedicated to accelerating healthcare and digital biology research using powerful combination of AI and simulation. – At the virtual inauguration, NVIDIA CEO and founder Jensen Huang discussed what NVIDIA’s $100 million investment will mean for the […]

  • 6 Key Ethical Principles for The Use of AI for Health – WHO

    – The World Health Organization (WHO) launched its first ever global report on: Ethics and governance of artificial intelligence for health.   – While new technologies that use artificial intelligence hold great promise to improve diagnosis, treatment, health research and drug development and to support governments carrying out public health functions, including surveillance and outbreak response, […]

  • EchoNous Closes $60M for AI-Assisted Handheld Ultrasound Device

    What You Should Know: – EchoNous, a Redmond, WA-based portable AI-guided ultrasound tools and platform, announced it has raised $60 million in funding from Kennedy Lewis Investment Management (“Kennedy Lewis”). – The investment from Kennedy Lewis combines senior secured debt and equity and builds on the support of KKR, which has been EchoNous’ principal investor […]

  • CareAlign, fixing that physician workflow–demo & interview

    By MATTHEW HOLT I recently interviewed Subha Airan-Javia, the CEO of CareAlign. CareAlign is a small company that is working to fix the clinician workflow by creating a tool for all those interstitial gaps that the big EMRs leave, and now get moved to and from paper by the care team. In this interview she […]

  • XSOLIS Raises $75M for AI-Driven Precision Utilization Management Platform

    What You Should Know: – XSOLIS, a healthcare technology firm focused on improving healthcare operations announced it has raised $75M in minority growth investment from Brighton Park Capital (“Brighton Park”), a research-driven investment firm. – XSOLIS is an artificial intelligence-based software platform that helps national health systems and payers streamline the utilization management process. – […]